Office of Prescription Drug Promotion (OPDP) has stepped up its enforcement efforts regarding prescription drug promotion, ...
Emails from an executive and sales staff falsely touted an inhaled steroid preparation as a treatment for COVID-19, prompting a warning from the branch of the US Food and Drug Administration (FDA) ...
On September 9, 2025, President Donald J. Trump signed a presidential memorandum targeting misleading drug advertising. This executive action aims to protect Americans by ensuring that ...
Dr. Marty Makary, the FDA commissioner, on Tuesday announced plans to curb misleading pharmaceutical ads by enforcing regulations against drug manufacturers who hide or downplay warnings and side ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results